Abstract:Aims: To characterise the detailed phenotype of "cone dystrophy with supernormal rod ERG" in a case series of 10 patients. Methods: 10 affected patients were examined clinically and underwent colour fundus photography, with nine undergoing detailed electrophysiological testing. Five patients were assessed further with fundus autofluorescence (AF) imaging, automated photopic and dark adapted perimetry, and dark adaptometry. Detailed colour vision assessment was performed in six subjects. Blood samples were taken from four patients for DNA extraction and mutation screening of NR2E3 was undertaken. Results: The onset of symptoms was in the first and second decades of life. Subjects presented with reduced central vision and marked photophobia. All individuals were myopic and colour vision testing revealed severely reduced colour discrimination predominantly along the red-green axes; tritan colour vision was relatively well preserved. Nyctalopia is a later feature of the disorder. Funduscopy and AF imaging revealed a range of macular appearances. There was electrophysiological evidence of marked macular dysfunction, reduced and delayed cone responses, and supernormal and delayed rod responses. Photopic and dark adapted perimetry revealed central scotomata with widespread peripheral sensitivity loss. No disease causing sequence variants in NR2E3 were identified. Conclusions: The largest case series to date has been described of the clinical, psychophysical and electrophysiological characteristics of this unusual cone dystrophy with supernormal rod responses. Electrophysiological data were consistent with a post-phototransduction, but pre-inner nuclear layer, site of dysfunction. While the definitive diagnosis can only be made with electrophysiological testing, several characteristics that may increase suspicion of this diagnosis are presented.

Mutations in the unfolded protein response regulator ATF6 cause the cone dysfunction disorder achromatopsia

Novel ATF6 Homozygous Variant in a Chinese Patient with Achromatopsia.

Mutation of CRYAB Encoding a Conserved Mitochondrial Chaperone and Anti-Apoptotic Protein Causes Hereditary Optic Atrophy.

Mitochondria and Endoplasmic Reticulum Stress in Retinal Organoids from Patients with Vision Loss

Biallelic Mutations in the Ferredoxin Reductase Gene Cause Novel Mitochondriopathy with Optic Atrophy

Cone photoreceptor function loss-3, a novel mouse model of achromatopsia due to a mutation in Gnat2

Gene Therapy for Achromatopsia

Comprehensive variant spectrum of the CNGA3 gene in patients affected by achromatopsia

Mutation in the Intracellular Chloride Channel CLCC1 Associated with Autosomal Recessive Retinitis Pigmentosa.

Excessive tubulin glutamylation leads to progressive cone-rod dystrophy and loss of outer segment integrity

A Novel OPA1 Mutation in a Chinese Family with Autosomal Dominant Optic Atrophy

GJA8 missense mutation disrupts hemichannels and induces cell apoptosis in human lens epithelial cells

A detailed phenotypic study of "cone dystrophy with supernormal rod ERG"

Expanding the genotypic and phenotypic spectra with a novel variant in the ciliopathy gene, CFAP410, associated with selective cone degeneration

THE GENETIC BASIS OF CLINICALLY SUSPECTED ACHROMATOPSIA IN THE UNITED ARAB EMIRATES

Structural and functional alterations associated with deutan N94K and R330Q mutations of green cone opsin

Rod photoreceptor clearance due to misfolded rhodopsin is linked to a DAMP-immune checkpoint switch

Abnormal Cone and Rod Photoreceptor Morphogenesis in gdf6a Mutant Zebrafish

Disease-causing mutations in genes encoding transcription factors critical for photoreceptor development

GENETIC ETIOLOGY AND CLINICAL FEATURES OF ACHROMATOPSIA IN JAPAN

Diagnostic fundus autofluorescence patterns in achromatopsia